Terms: = Kidney tumors AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184
119 results:
1. Construction of a prognostic model for autophagy in Wilm's tumor.
Shi H; Zhang M; Zhang Y
Pediatr Surg Int; 2024 May; 40(1):122. PubMed ID: 38704513
[TBL] [Abstract] [Full Text] [Related]
2. KLF9 inhibits the proliferation, invasion, and migration of renal cell carcinoma through the SDF-1/cxcr4 axis.
Yu P; Cheng L; Xia WM; Liu DY; Yu JS; Zhou YF; Zheng YJ
Kaohsiung J Med Sci; 2023 Jun; 39(6):587-595. PubMed ID: 37010151
[TBL] [Abstract] [Full Text] [Related]
3. Differential Expression and Clinical Relevance of C-X-C Motif Chemokine Receptor 4 (cxcr4) in Renal Cell Carcinomas, Benign Renal tumors, and Metastases.
Maas M; Kurcz A; Hennenlotter J; Scharpf M; Fend F; Walz S; Stühler V; Todenhöfer T; Stenzl A; Bedke J; Rausch S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982302
[TBL] [Abstract] [Full Text] [Related]
4. On-Chip Organoid Formation to Study cxcr4/CXCL-12 Chemokine Microenvironment Responses for Renal Cancer Drug Testing.
Ozcelik A; Abas BI; Erdogan O; Cevik E; Cevik O
Biosensors (Basel); 2022 Dec; 12(12):. PubMed ID: 36551144
[TBL] [Abstract] [Full Text] [Related]
5. CD70-Targeted Micelles Enhance HIF2α siRNA Delivery and Inhibit Oncogenic Functions in Patient-Derived Clear Cell Renal Carcinoma Cells.
Trac N; Oh HS; Jones LI; Caliliw R; Ohtake S; Shuch B; Chung EJ
Molecules; 2022 Dec; 27(23):. PubMed ID: 36500549
[TBL] [Abstract] [Full Text] [Related]
6. MT1X is an oncogene and indicates prognosis in ccRCC.
Ding Y; Fang J; Chen M; Xu Y; Liu N; Fang S; Xiang W; Chen R; Wu C; Yu H
Biosci Rep; 2022 Oct; 42(10):. PubMed ID: 36149322
[TBL] [Abstract] [Full Text] [Related]
7. Tumor-infiltrated activated B cells suppress liver metastasis of colorectal cancers.
Xu Y; Wei Z; Feng M; Zhu D; Mei S; Wu Z; Feng Q; Chang W; Ji M; Liu C; Zhu Y; Shen L; Yang F; Chen Y; Feng Y; Xu J; Zhu D
Cell Rep; 2022 Aug; 40(9):111295. PubMed ID: 36044847
[TBL] [Abstract] [Full Text] [Related]
8. A systematic analysis of molecular mechanisms in non-metastatic renal cancer delineates affected regulatory pathways and genes in tumor growth.
Xia R; Lin L; Yu S; Zhang J; Zheng L; Zhou L; Lin J
Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(5):427-438. PubMed ID: 35818225
[TBL] [Abstract] [Full Text] [Related]
9. Lox as the Potential Key Gene of Clear Cell Renal Carcinoma.
Chen Y; Yan Z; Su Y; Zhao S
J Coll Physicians Surg Pak; 2022 May; 32(5):632-638. PubMed ID: 35546701
[TBL] [Abstract] [Full Text] [Related]
10. The post-transcriptional inhibition of cxcr4 expression by miR-139 regulates the proliferation of human kidney cancer cells.
Yu P; Liu JX; Zhang Y; Ge YZ; Liu H; Qiu J; Liu W
Acta Biochim Pol; 2022 Feb; 69(1):189-195. PubMed ID: 35226449
[TBL] [Abstract] [Full Text] [Related]
11. PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating cxcr4/ERK signaling pathway and accelerating glycolysis.
He Y; Wang X; Lu W; Zhang D; Huang L; Luo Y; Xiong L; Li H; Zhang P; Li Q; Liang S
Cell Death Dis; 2022 Feb; 13(2):118. PubMed ID: 35121728
[TBL] [Abstract] [Full Text] [Related]
12. FGD5 regulates endothelial cell PI3 kinase-β to promote neo-angiogenesis.
Azad AK; Farhan MA; Murray CR; Suzuki K; Eitzen G; Touret N; Moore RB; Murray AG
FASEB J; 2022 Jan; 36(1):e22080. PubMed ID: 34882832
[TBL] [Abstract] [Full Text] [Related]
13. Expression of the cxcr4 and CXCR7 in renal cancers; can "the orphan receptor" predict the mortality?
Floranović MP; Petrović AR; Veličković LJ
Ann Diagn Pathol; 2021 Dec; 55():151829. PubMed ID: 34563828
[TBL] [Abstract] [Full Text] [Related]
14. A Prognostic Nomogram for Predicting Overall Survival in Pediatric Wilms Tumor Based on an Autophagy-related Gene Signature.
He L; Wang X; Jin Y; Xu W; Lyu J; Guan Y; Wu J; Han S; Liu G
Comb Chem High Throughput Screen; 2022; 25(8):1385-1397. PubMed ID: 34525929
[TBL] [Abstract] [Full Text] [Related]
15. Ceruloplasmin overexpression is associated with oncogenic pathways and poorer survival rates in clear-cell renal cell carcinoma.
Zhang Y; Chen Z; Chen JG; Chen XF; Gu DH; Liu ZM; Gao YD; Zheng B
FEBS Open Bio; 2021 Nov; 11(11):2988-3004. PubMed ID: 34449964
[TBL] [Abstract] [Full Text] [Related]
16. Biokinetics and Dosimetry of
Hänscheid H; Schirbel A; Hartrampf P; Kraus S; Werner RA; Einsele H; Wester HJ; Lassmann M; Kortüm M; Buck AK
J Nucl Med; 2022 May; 63(5):754-760. PubMed ID: 34413147
[TBL] [Abstract] [Full Text] [Related]
17. Bioinformatics analysis of C3 and cxcr4 demonstrates their potential as prognostic biomarkers in clear cell renal cell carcinoma (ccRCC).
Quan J; Bai Y; Yang Y; Han EL; Bai H; Zhang Q; Zhang D
BMC Cancer; 2021 Jul; 21(1):814. PubMed ID: 34266404
[TBL] [Abstract] [Full Text] [Related]
18. Silencing of the chemokine CXC receptor 4 (cxcr4) hampers cancer progression and increases cisplatin (DDP)-sensitivity in clear cell renal cell carcinoma (ccRCC).
Wang W; Gan Z; Liu Q; Yan S; Mulati R; Wang Y
Bioengineered; 2021 Dec; 12(1):2957-2969. PubMed ID: 34180759
[TBL] [Abstract] [Full Text] [Related]
19. Expression and prognostic value of CXCL12/cxcr4/CXCR7 axis in clear cell renal cell carcinoma.
Potić Floranović M; Ristić Petrović A; Veličković F; Janković Veličković L
Clin Exp Nephrol; 2021 Oct; 25(10):1057-1069. PubMed ID: 34109508
[TBL] [Abstract] [Full Text] [Related]
20. Hypoxia-induced lncHILAR promotes renal cancer metastasis via ceRNA for the miR-613/206/ 1-1-3p/Jagged-1/Notch/cxcr4 signaling pathway.
Hu G; Ma J; Zhang J; Chen Y; Liu H; Huang Y; Zheng J; Xu Y; Xue W; Zhai W
Mol Ther; 2021 Oct; 29(10):2979-2994. PubMed ID: 34058384
[TBL] [Abstract] [Full Text] [Related]
[Next]
